Wearable technology that quantifies daily physical activity, such as FitBit One, can help determine mobility patterns and evaluate the…
Articles by Alice Melao
Magnetic resonance imaging (MRI) showing an abnormally bright signal in the tongue is common among patients with late-onset Pompe…
Salmeterol, a vasodilator approved for the treatment of asthma and chronic obstructive pulmonary disease (COPD), has shown potential to…
New genetic mutations and uncommon clinical symptoms, including skeletal alterations and developmental delay, were linked to juvenile-onset Pompe disease in…
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Amicus Therapeutics’ lead therapy…
Manifestations of Pompe disease — its suspected signs or symptoms — can mimic diagnostic findings of a rare type of…
A research team in Korea has developed a new method using rice to produce lab-made human acid alpha-glucosidase (GAA) for…
Amicus Therapeutics is planning to launch a pivotal trial to compare its investigational therapy AT-GAA (ATB200/AT221) to the…
Magnetic resonance imaging (MRI) seems to be an effective and efficient tool to evaluate muscular status and monitor patients with…
Treatment with Lumizyme (alglucosidase alfa) at double the approved dose may help prevent the rapid decline of respiratory and…